FindTrial
Sign In

CRIP1 regulates epithelial mesenchymal transformation and promotes the development of epithelial ovarian cancer: a medical records based retrospective study

CRIP1 regulates epithelial mesenchymal transformation and promotes the development of epithelial ovarian cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041255
Enrollment
Unknown
Registered
2020-12-23
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epithelial ovarian cancer

Interventions

case series:Nil

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The patient was diagnosed as serous cystadenocarcinoma of ovary by surgical pathology.

Exclusion criteria

Exclusion criteria: Exclude patients with other cancers and patients who had received immunotherapy or radiotherapy or chemotherapy before surgery.

Design outcomes

Primary

MeasureTime frame
Cysteine-Rich intestinal Protein 1, CRIP1;—

Countries

China

Contacts

Public ContactFen Fu

The Second Affiliated Hospital of Nanchang University

fu_fen@163.com+86 13330127680

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026